Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Martine, van Glabbeke"'
Autor:
Pancras C.W. Hogendoorn, Jean Yves Blay, Raf Sciot, Ulrike Schneider, Philippe Terrier, Jaap Verweij, Jan Oosting, Ronald Van Eijk, Paola Comite, Heidi Van Paassen, Martine Van Glabbeke, Maria Debiec-Rychter, Salvatore Romeo
Supplementary Data from Cell Cycle/Apoptosis Molecule Expression Correlates with Imatinib Response in Patients with Advanced Gastrointestinal Stromal Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27af88ad528303b52632f2b5b52046dd
https://doi.org/10.1158/1078-0432.22440205.v1
https://doi.org/10.1158/1078-0432.22440205.v1
Autor:
Peter Hohenberger, Jean-Yves Blay, Paolo Casali, Jaap Verweij, Ian Judson, Serge Leyvraz, Olivier Bouché, Emmanuelle Bompas, François Bertucci, Antoine Adenis, Bruno Landi, Javier Martin-Broto, Florence Duffaud, Jean-François Emile, Maria Debiec-Rychter, Martine Van Glabbeke, Patrick Schöffski, Piotr Rutkowski, Elena Fumagalli, Philippe A. Cassier
PDF file, 60KB, Progression-free (panel A) and overall (panel B) survival according to the mitosis count. HPF: high power field.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e44b061065a85782069ee7205e88f9c
https://doi.org/10.1158/1078-0432.22442781.v1
https://doi.org/10.1158/1078-0432.22442781.v1
Autor:
Pancras C.W. Hogendoorn, Jean Yves Blay, Raf Sciot, Ulrike Schneider, Philippe Terrier, Jaap Verweij, Jan Oosting, Ronald Van Eijk, Paola Comite, Heidi Van Paassen, Martine Van Glabbeke, Maria Debiec-Rychter, Salvatore Romeo
Purpose: Altered expression of cell cycle/apoptosis key regulators may promote tumor progression, reflect secondary genetic/epigenetic events, and impair the effectiveness of therapy. Their expression pattern might then identify gastrointestinal stro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470591f8af344451bcf5b46a19d584cb
https://doi.org/10.1158/1078-0432.c.6517564.v1
https://doi.org/10.1158/1078-0432.c.6517564.v1
Autor:
Peter Hohenberger, Jean-Yves Blay, Paolo Casali, Jaap Verweij, Ian Judson, Serge Leyvraz, Olivier Bouché, Emmanuelle Bompas, François Bertucci, Antoine Adenis, Bruno Landi, Javier Martin-Broto, Florence Duffaud, Jean-François Emile, Maria Debiec-Rychter, Martine Van Glabbeke, Patrick Schöffski, Piotr Rutkowski, Elena Fumagalli, Philippe A. Cassier
Purpose: Platelet-derived growth factor receptor-alpha (PDGFRA) mutations are found in approximately 5% to 7% of advanced gastrointestinal stromal tumors (GIST). We sought to extensively assess the activity of imatinib in this subgroup.Experimental D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2adfdadc9eac492a41c20c968baae86b
https://doi.org/10.1158/1078-0432.c.6519447
https://doi.org/10.1158/1078-0432.c.6519447
Autor:
Ole S. Nielsen, Per Dombernowsky, Henning Mouridsen, Søren Daugaard, Martine Van Glabbeke, Anne Kirkpatrick, Jaap Verweij
Publikováno v:
Sarcoma, Vol 4, Iss 1-2, Pp 31-35 (2000)
Purpose. Doxorubicin (dox) still appears to be one of the most active drugs in the treatment of soft tissue sarcomas. However, treatment duration is limited due to cumulative cardiotoxicity. A number of small studies from single institutions have sug
Externí odkaz:
https://doaj.org/article/877a787ac2b44e61b19b98367642c66c
Autor:
Daphne de Jong, Ad Koster, Anton Hagenbeek, John Raemaekers, Dennis Veldhuizen, Sabien Heisterkamp, Jan Paul de Boer, Martine van Glabbeke
Publikováno v:
Haematologica, Vol 94, Iss 1 (2009)
Background The clinical behavior of follicular lymphoma is largely determined by properties of the non-malignant tumor microenvironment. The precise nature of the cell populations is still unclear and published data on their prognostic significance a
Externí odkaz:
https://doaj.org/article/028fbf13167b4e67b3fde2c4744ba9e2
Autor:
Jean-Yves Blay, Javier Martin-Broto, Piotr Rutkowski, Florence Duffaud, Emmanuelle Bompas, Serge Leyvraz, Maria Debiec-Rychter, Elena Fumagalli, Martine Van Glabbeke, Olivier Bouché, Philippe A. Cassier, Paolo G. Casali, Bruno Landi, Antoine Adenis, Jean-François Emile, Peter Hohenberger, François Bertucci, Jaap Verweij, Ian Judson, Patrick Schöffski
Publikováno v:
Clinical Cancer Research, 18(16), 4458-4464. American Association for Cancer Research Inc.
Clinical Cancer Research
Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩
Clinical Cancer Research
Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩
Purpose: Platelet-derived growth factor receptor-alpha (PDGFRA) mutations are found in approximately 5% to 7% of advanced gastrointestinal stromal tumors (GIST). We sought to extensively assess the activity of imatinib in this subgroup. Experimental
Autor:
Pancras C.W. Hogendoorn, Matthew R. Sydes, Ian Lewis, Antonie H. M. Taminiau, M. Nooij, Martine Van Glabbeke, Hans Gelderblom, B. M. Uscinska, Anne McTiernan, Jeremy Whelan, Jane Hook, Vivien H.C. Bramwell, Rachel C. Jinks
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 48(5), 703-712
European Journal of Cancer, 48(5), 703-712
Aim Chemotherapy-induced toxicity is an independent prognostic indicator in several cancers. We aimed to determine whether toxicity was related to survival and histological response in high-grade localised extremity osteosarcoma. We undertook a retro
Autor:
Sabrina Rossi, Luisa Toffolatti, Beatrice Seddon, Jaap Verweij, Manuel Rodriguez-Justo, Chiara Sartor, Angelo Paolo Dei Tos, Marco Novelli, Jean-Yves Blay, Peter Hohenberger, Pancras C.W. Hogendoorn, Martine Van Glabbeke, Philippe Taniere, Adrienne M. Flanagan, Raphael Sciot
Publikováno v:
Histopathology. 57:259-270
Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, Sartor C, Hogendoorn P C W, Sciot R, Van Glabbeke M, Verweij J, Blay J Y, Hohenberger P, Flanagan A & Dei Tos A P (2010) Histopathology57, 259–270 DOG1 and CD117 are the anti
Autor:
Andrej Vranovsky, Robert Marcus, Richard Klasa, Mars B. van ‘t Veer, Marinus H. J. van Oers, Max Wolf, Harald Holte, Eva Kimby, Martine Van Glabbeke, Anton Hagenbeek, Livia Giurgea
Publikováno v:
Journal of clinical oncology, 28(17), 2853-2858. American Society of Clinical Oncology
Purpose In 2006, we published the results of the European Organisation for Research and Treatment of Cancer phase III trial EORTC 20981 on the role of rituximab in remission induction and maintenance treatment of relapsed/resistant follicular lymphom